$IOSP

Looking Into Innospec Inc's Recent Short Interest - Innospec (NASDAQ:IOSP)

Innospec Inc's ( NYSE:IOSP ) short interest as a percent of float has risen 36.67% since its last report. According to exchange reported data, there are now 579 thousand shares sold short, which is 3.28% of all regular shares that are available for trading.

Original reporting
Benzinga · Benzinga Insights
Published Nov 4, 2025, 8:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 4, 2025, 8:31 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$IOSP
Neutral
medium confidence
Mentioned
$IOSP
Relevance
6/10
AlphAI data visualization · based on Benzinga
Decision brief

The 30-second read

$IOSPNeutralLow
01

Why it matters

The short interest increase is modest and may not significantly influence the stock's price without additional supporting news or market movements.

02

Market read

Limited immediate trading impact; relevant primarily for short-term traders and those monitoring sector sentiment.

03

What to watch

Lack of recent positive catalysts and overall market conditions could limit upside potential.

Relevance 6/10Timing: short-term

Background

Innospec Inc has experienced a recent rise in short interest, which could reflect trader expectations of a decline or profit-taking strategies.

Company-level read

Ticker impact

$IOSPNeutralMedium confidence
Context

The recent increase in short interest suggests a potential bearish sentiment among traders, but the overall relevance score indicates limited immediate impact on the stock's price movement.

Expected impact

Moderate potential for short-term decline, but unlikely to cause significant price movement without additional catalysts.

Evidence & confidence

While increased short interest can signal bearish sentiment, the low overall short interest percentage and absence of other negative news imply limited immediate impact.

Market effects

Potential cautiousness in the Life Sciences sector due to increased short interest in related stocks.

Minimal regional impact expected.

Limited global market relevance; specific to the company's sector and stock.

Counterpoint

The increase in short interest may be a contrarian indicator, suggesting that the stock could rebound if short sellers cover positions.

Key entities

  • Innospec Inc

    A specialty chemicals company listed on NASDAQ.

Related articles

$IOSPMedAI 8/10

Innospec’s (IOSP) Strong Quarter Hides A Cash Flow Problem Worth Watching

Innospec (IOSP) reported Q2 revenue up 12% to $491.4M, with all three segments showing growth. Net income rose to $30.8M. However, operating cash flow fell to $24.8M, and working capital changes consumed $60.9M. Margins declined in two segments, and adjusted EBITDA dropped to $93.8M. The company remains debt-free with $250.2M in net cash, paying dividends and repurchasing shares.

$IOSPMedAI 8/10

Innospec (IOSP) Q2 2026 Earnings Call Transcript

Innospec reported Q2 2026 revenue of $491.4 million, up 12% year over year, and net income of $30.8 million ($1.25 diluted EPS). Adjusted EPS was $1.27 and adjusted EBITDA $50.1 million. Segment results included higher Performance Chemicals, Fuel Specialties, and Oilfield Services. Management cited supply constraints from plant repairs and said DRA capacity is almost sold out.

$IOSPMed

Innospec Q2 Earnings Call Highlights

Innospec (NASDAQ:IOSP) Q2 call: CEO Patrick Williams said Performance Chemicals benefited from operating leverage, Fuel Specialties stayed within targeted margins, and Oilfield Services improved sequentially and YoY on expanded DRA capacity. North Carolina repairs are ~60% complete, with full optimization by Q4. Management expects Q3 segment results broadly similar, plus operating-income growth in H2 2026. Cash from ops was $7.2M before $16.5M capex; $250.2M cash, no debt; repurchased 87k shares

$IOSPMed

Innospec REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS

INNOSPEC INC. (IOSP) filed an SEC Form 8-K — Results of Operations and Financial Condition. Innospec REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS Strong contributions from all businesses with revenues up 12 percent and operating income up 16 percent Continued strength in Fuel Specialties and further improvement in Performance Chemicals and Oilfield Services Debt-free b

$GMMed

GM’s Electric Vehicle Sales Fell Off A Cliff Last Quarter

General Motors reported a significant decline in U.S. EV sales in Q3, with Cadillac, Chevrolet, and GMC brands all seeing drops. Cadillac's total sales fell 30% to 32,650. Chevrolet's sales declined 4.6% to 437,321, with the Equinox EV down 92.4%. GMC's Hummer EV sales dropped 72.9%. Overall, GM's Q3 sales fell 5.5% to 670,974, and year-to-date sales are down 6.4%.